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ABSTRACT  
 
Background: Smoking prevalence remains significantly higher amongst individuals with 
mental health conditions compared with the general population. Tobacco harm reduction 
(THR) in the form of replacing cigarettes for electronic cigarettes (ECs) is an alternative 
approach which may prove useful for these smokers who find it difficult to quit. Exploring how 
mental health professionals’ (MHPs) perceive ECs, and how these influence decision making 
regarding their use in clinical settings is essential to determine the feasibility of incorporating 
ECs into the treatment pathway. 
Methods: We conducted six focus groups between March and August 2017. A total of 39 
MHPs were recruited from mental healthcare services in England. Discussions were guided by 
a semi-structured guide, and responses were recorded, transcribed and coded using thematic 
framework analysis.  
Results: MHPs generally adopt a risk-averse approach when judging the safety and suitability 
of ECs. Risk-aversion was influenced by perceived obscurity surrounding ECs and THR, as 
well as high exposure to adverse and unreliable information regarding ECs, and perceived 
analogies between ECs and conventional cigarettes. Some MHPs adopt a pragmatic approach 
when making decisions based on THR and EC use in daily practice by considering the context 
of treatment and patient circumstances. However, this is often accompanied by a high degree 
of caution and misperceptions which limits the potential benefit this intervention could have in 
mental healthcare settings.  
Conclusion: Improved dissemination of national guidance and scientific literature regarding 
THR and ECs is essential in mental healthcare to eliminate misperceptions and better inform 
MHPs evidence-based decision-making practices. 
Keywords: Tobacco harm reduction; Electronic cigarettes, E-cigarettes; Mental healthcare; 
Qualitative research 
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1.BACKGROUND 
 
Tobacco control is a key government initiative within the United Kingdom (UK) (1). In 
England, smoking prevalence in the general population has declined from 24% in 2007, to 
14.9% in 2017 (2). However, smoking prevalence among individuals with mental health 
conditions in England has remained high; estimated at around 34.1% in 2014 (3). 
Consequently, smoking within this population contributes to an average of 17 life years lost 
(4). Specifically, in the United States (US), research indicates that smokers with severe 
psychological distress (SPD) lose 14.9 years of life relative to never-smokers without SPD, 
and 9.6 years relative to non-smokers with SPD (5). In an attempt to reduce smoking 
prevalence in disadvantaged populations such as those with mental health conditions, the 
National Institute for Health and Care Excellence (NICE) in the UK has issued guidance and 
recommendations to adopt tobacco harm reduction (THR) as an alternative approach to 
cessation for those who find it difficult to quit (6). THR is a strategy in which smokers are 
able to substitute cigarettes for less harmful nicotine-containing products, thus essentially 
maintaining a desired level of nicotine intake while minimising exposure to harmful chemical 
components present in tobacco smoke (7).  
Smoking is a complex bio-psycho-social behaviour incorporating biological 
dependency, habits, beliefs and identity (8). Although traditionally licensed harm reduction 
products such as nicotine replacement therapies (NRT) deliver nicotine to the user and thus 
satisfy the biological dependency, these products fail to address the behavioural and social 
aspects of smoking. Subsequently, these products may not be well suited for highly 
dependent smokers, such as those with mental health conditions (9). In contrast, electronic 
cigarettes (ECs) relieve nicotine cravings, while simultaneously replacing the behavioural 
and social aspects of smoking (10,11). ECs are able to achieve this as they are non-
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combustible, non-tobacco products, which typically allow the user to inhale a vaporous 
solution of nicotine suspended in a humectant (typically propylene glycol and glycerine), thus 
providing nicotine delivery via a hand-to-mouth movement (12). In the UK, these products 
have become the most popular smoking cessation aid, with an estimated 3.2 million EC users 
in 2017 (13). Furthermore, as more evidence emerges supporting their use for harm reduction 
purposes, bodies such as Public Health England (PHE) and the Royal College of Physicians 
(RCP) in the UK, as well as the National Academy of Sciences in the US, have concluded 
that smokers who are unable to quit should consider converting to vaping as a safer 
alternative to conventional cigarettes (7,12,14).  
In the context of mental healthcare, ECs may be one solution to reduce smoking in 
these settings by functioning as a safer source of nicotine (9). Research from the US indicates 
that smokers with mental health conditions are more likely to have tried an EC and be a 
current EC user in comparison to smokers in the general population (15). What is more, a 
small number of randomised controlled trials (RCTs) and pilot studies from Italy (16), 
Australia (17) and the UK (18,19) have found that ECs are effective in supporting smoking 
cessation and harm reduction among smokers with mental illnesses. As a result of this 
growing body of evidence, the Science and Technology Committee in London, England, have 
advised mental health trusts to allow EC use on their premises (20). 
However, research has found that MHPs are often reluctant to support their patients to 
address their smoking, due to widely held misconceptions regarding the necessity and 
appropriateness of smoking cessation interventions in mental healthcare (21). Specifically, 
MHPs hold intrinsic biases regarding patients’ abilities and motivation to quit, and believe 
quitting smoking is too much for patients to take on (21). Nevertheless, it remains unclear as 
to whether MHPs would be willing to support ECs and THR as an alternative approach to 
cessation. Research to date has only explored the acceptability of ECs among general 
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healthcare personnel, with findings showing a degree of support from some (22,23), and lack 
of support from others (24,25). In any instance, misperceptions and concerns are prominent 
among healthcare personnel (26–28), though there is some research to suggest that there is 
high demand among healthcare personnel to know more about ECs in order to better inform 
decisions regarding their use by patients (28). However, no research exists exploring this 
among those working specifically with smokers who have mental health conditions. This is of 
particular interest given that smokers with mental health conditions are likely to turn to their 
healthcare providers for advice and information regarding these products.  
In light of the NICE guidance regarding THR, as well as the recommendations from 
PHE and RCP regarding the use of ECs for smokers with mental illnesses, the present study 
aims to qualitatively explore how MHPs perceive THR and ECs, and how these influence 
their decisions regarding their use in clinical settings.  
 
2.METHODS 
 
2.1 Sample and recruitment 
 
To recruit a diverse participant group to resemble the multidisciplinary nature of mental 
healthcare teams, a stratified purposive sampling method was adopted. The lead author (CS) 
achieved this by using the NHS England website to search for appropriate mental health 
services local to the author that treated a diverse range of mental health conditions. CS 
contacted appropriate services via email, and those who indicated interest and capacity to 
participate were forwarded further information about the purpose of the study.  
 
In total, 39 MHPs participated in the present study; 36 were recruited from five services 
within one of the largest mental health trusts in Europe, and 3 were recruited from one 
service within another mental health trust in London (See table 1 for a breakdown of 
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participant and service characteristics). Services specialised in treatment for a range of mental 
health conditions, including common mental disorders (e.g. anxiety and depression), mood 
disorders, psychosis and personality disorders.  
 
Table 1: Participant and service characteristics 
Participant characteristics (n=39) Mean (SD) 
Age (years) 37.4 (13.5)* 
Years in current role  6.4 (7.8)* 
Gender  n (%) 
Male 11 (28.2) 
Female  28 (71.8) 
Service type   n (%) 
Secondary care inpatient wards  1 (16.7) 
Secondary care community services  3 (50) 
Primary care community services 2 (33.3) 
Participants in each service n (%) 
Secondary care inpatient wards 4 (10.3) 
Secondary care community services 15 (38.5) 
Primary care community services  20 (51.3) 
Professional discipline  n (%) 
Occupational Therapist**  1 (2.6) 
Psychiatrist 4 (10.3) 
Clinical Psychologist**  4 (10.3) 
Trainee Clinical Psychologist 2 (5.1) 
Health Psychologist 1 (2.6) 
Assistant Psychologist 1 (2.6) 
Psychological Wellbeing Practitioner 
(PWP) 
8 (20.5) 
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Trainee PWP 2 (5.1) 
IAPTS placement student  1 (2.6) 
Cognitive Behavioural Therapy (SBT) 
Therapist 
1 (2.6) 
Nurse**  5 (12.9) 
Student Nurse 1 (2.6) 
Social worker  4 (10.3) 
Forensic Mental Health Practitioner 1 (2.6) 
Support worker  1 (2.6) 
Administrator/assistant 2 (5.1) 
Self-reported smoking status  n (%) 
Non-Smoker 18 (46.2) 
Ex-Smoker 14 (35.9) 
Occasional/social smoker 6 (15.4) 
Smoker 1 (2.6)  
*Age was not disclosed by 6 MHPs 
** Includes acting service leaders (one occupational therapist, one clinical psychologist, and three 
nurses).  
 
2.2 Data collection 
 
A total of six focus groups (one for each participating service) were conducted between 
March and August 2017, with each lasting 45 – 60 minutes. The decision to conduct focus 
groups over individual interviews was made following two pilot interviews and one pilot 
focus group, where it was decided that focus groups allowed for more broadening exploration 
and opportunity for MHPs to generate and share ideas/concerns regarding ECs and harm 
reduction. The rationale for conducting focus groups for each service individually was that 
participants would be able to engage in honest and elaborative discussion regarding ECs and 
THR with known colleagues, thus theoretically increasing the real-life applicability of this 
study’s findings by providing insight into the decision-making processes of multidisciplinary 
teams.  
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The focus groups were facilitated by CS, with the assistance of ZA. All focus groups began 
with everyone introducing themselves to the group. CS and ZA explained the purpose of the 
focus group, which was read from the topic guide (appendix 1). Participants were provided 
with the opportunity to ask questions after the information sheet was provided and read aloud 
by CS or ZA, and participants were asked to provide written consent before the focus groups 
began. All focus groups were conducted in an interview room on the hospital site where the 
services were based.  
 
The facilitators used a semi-structured interview guide to direct the discussions and prompt 
MHPs when needed. This guide was informed following a review of the literature and was 
refined using an iterative process following piloting in two interviews and one focus group 
before the study began. The final topic guide (appendix 1) covered numerous topics relating 
to tobacco control interventions and mental health:  
1. Experiences of providing patients with smoking cessation support  
2. Attitudes/perceptions toward THR 
3. Attitudes/perceptions toward ECs 
4. Attitudes/compliance of smoke-free policy in mental healthcare 
For the purpose of the aims of this research paper, the data obtained from questions three and 
four (regarding THR and ECs) were included in the analysis of this paper. Data regarding 
MHPs’ experiences of providing smoking cessation interventions and attitudes/compliance 
toward the smoke-free policy are reported in another qualitative paper by the same authors 
(29).  
2.3 Ethical considerations and review 
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Participants received an information sheet at the start of each focus group. This information 
was read aloud by either CS or ZA at the start of each focus group. Participants were advised 
orally of their rights and were assured of anonymity before they provided written consent. 
The project was reviewed and approved by the University College London ethics committee 
(application reference 10093/001).  
 
2.4 Data analysis 
 
With participants’ permission, focus groups were audio recorded and transcribed verbatim by 
CS, and were checked for accuracy by ZA. Transcripts were interpreted and analysed using 
thematic analysis with the framework method (30). This approach was chosen as framework 
analysis consists of clearly defined steps to follow and produces highly structured outputs of 
summarised data. Data was managed using Nvivo (version 11) software (31) where authors 
(CS, LK and ZA) recorded initial descriptive themes that aligned with a cognitive psychology 
perspective, due to the nature of the study’s aims. These authors independently developed 
over-arching themes and sub-themes, before reviewing each other’s draft themes and 
developing an agreed interpretation with the input from fellow authors (AM and LS). CS 
charted the data into a framework matrix, which involved summarizing the data for each 
theme and case. Finally, a developed interpretive framework was produced by CS, and the 
remaining authors reviewed and agreed on the final framework.  
 
3. RESULTS  
Theme 1: MHPs adopt a risk-averse approach when forming perceptions and 
judgements regarding ECs safety and suitability.   
Sub-theme 1: Perceived obscurity surrounding THR and ECs facilitate misconceptions among 
MHPs.  
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MHPs generally indicated a lack of awareness and knowledge of ECs and THR. MHPs that 
had more knowledge about ECs, and the impact of tobacco use on the mental health 
population, supported the use of ECs in mental healthcare. However, many MHPs were 
unaware of the literature available on ECs. Uncertainty regarding the contents of ECs led 
some MHPs to be cautious in their judgements by questioning whether ECs are indeed a 
‘safer’ alternative to smoking: 
“It’s difficult to know as well how bad e-cigarettes are. I don’t think there is much 
research or general information about what are the dangers, because they are a 
relatively new thing. So I guess having a safe alternative; what does that actually 
mean? What is a safe alternative? Are e-cigarettes a safe alternative?” (Robbie, 
Community Setting, PWP, Non-Smoker).  
In many cases, MHPs indicated their personal preferences for traditional NRT over ECs, in 
spite of recognising patients are generally not interested in these products. However, this was 
often in the context of cessation. Many MHPs were cautious to recommend ECs over NRT, 
as ECs were perceived less as an intervention to smoking and more as a potential lifestyle:  
“I think with NRT there is that expectation that you are going to reduce down, so it’s 
clearer. But with vaping, maybe not so much, and the paraphernalia around it, there 
is more potential for it to be a lifestyle rather than a stepping stone towards complete 
cessation.” (Margaret, Community Setting, Clinical Psychologist, Non-Smoker). 
This uncertainty surrounding the benefits of THR and ECs often perpetuated MHPs beliefs 
that ECs are products which prolong nicotine addiction, rather than support patients to 
overcome an addiction. This continued use of nicotine was perceived by many to be 
problematic, which impaired MHPs ability to recognise the benefit of ECs, and in some cases 
NRT use, over combustible tobacco use: 
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 “There is a plastic thing, a small one. I don’t think I’ve ever seen someone suck on 
anything as hard on that than the patients on the ward when they were given that 
instead of access to cigarettes. It almost seemed their nicotine intake was more than if 
they just had the odd fag during the day because they were constantly 24 hours a day 
you would see them, then they would go and get a refill. Really sucking really 
deeply… I don’t know what it does or what’s in it, but it just struck me… I couldn’t 
really see what the point of it was other than stopping them for actually inhaling 
smoke.” (Nigel, Community Setting, Clinical Psychologist, Ex-Smoker) 
[…] 
“The more it goes on the more upset I am about prescribing all these extras because 
sometimes people use more nicotine than if they were allowed to smoke every two 
hours.” (Kelly, Community Setting, Psychiatrist, Ex-Smoker) 
Sub-theme 2: Increased engagement with unreliable information sources over trust resources 
perpetuate misconceptions among MHPs. 
 
The majority of MHPs were unaware of their trust’s smoke-free policy with regard to EC use, 
although many MHPs spoke about completing an annual online smoking cessation training 
module which forms part of their mandatory professional development. However, only a 
minority of MHPs recalled content regarding EC use, and only one MHP indicated that they 
had read scientific literature supporting EC use in comparison with cigarettes: 
“I think there has been recent literature published that suggests the harms from e-
cigarettes in their current commercialised state are less than the harms from 
cigarettes” (Sharon, Community Service, Psychiatrist, Ex-Smoker).  
In contrast, the majority of MHPs were unable to recall EC content covered on the training 
module which they had completed in the past year, and in one case, the day before the focus 
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group. Yet, many recalled extreme cases of where they had heard or read ECs to be 
dangerous or destabilising to wider tobacco control policy: 
“I can’t remember if ECs are covered in the e-learning… I can’t remember if I read 
or heard it, but it was over the weekend, that young people are taking up vaping 
rather than smoking, which that’s not what its meant to be… its meant to be an aid to 
stopping, isn’t it.” (Hannah, Community Service, Nurse & Team Leader, Social 
Smoker)  
[…] 
“I read something in the paper that the percentage of harm they are doing compared 
to cigarettes is not a lot of percentage difference.” (Charlotte, Inpatient Service, 
Admin and ward assistant, Non-Smoker).  
[…] 
“When I did my e-learning yesterday they had all these awful chemicals in a 
cigarette; arsenic and you mentioned tar, and toxins really that are in the cigarette. 
So is that not in the e-cigarette?”(Debbie, Inpatient Service, Nurse and Manager, 
Ex-Smoker) 
In rare instances, this was taken further by some MHPs who stated that any nicotine use 
poses threat to users’ health:  
“Well look at the spray, do you remember the spray? I swear they said it was causing 
tongue cancer or throat cancer. So I think if you want to stop smoking you should just 
stop altogether… I don’t think NHS should be prescribing nicotine for people at all.” 
(Mandy, Community Service, Social Worker, Ex-Smoker). 
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Sub-theme 3: Analogies between ECs and conventional cigarettes triggers suspicion among 
MHPs when making judgements regarding THR and ECs.  
 
Much criticism directed toward ECs appeared to be somewhat driven by the perceived 
similarities between ECs and cigarettes; including visual stimuli and behavioural actions 
produced during the use of both products. This appeared to lead many MHPs to mistakenly 
consider ECs to be a “type” of conventional cigarette, whereby the same guidelines and 
terminology would apply to these users. These MHPs therefore did not see the benefit of 
substituting a cigarette for an EC: 
“I think sometimes if you want a cigarette you kind of want the real thing. I don’t 
know how helpful ECs would be because it would still be the same rules that you 
would have to leave and smoke, you couldn’t smoke on the wards, and with e-
cigarettes it’s the behaviour you have to look at.” (Charlie, Community Setting, 
Mental Health Practitioner, Social Smoker).  
Even among MHPs who had used ECs and thus supported their use for THR, the perceived 
similarities shared between smoking and vaping influenced the language which was used 
when discussing past experiences of using these products. One occasional smoker who 
considered himself an “ex-vaper” believed ECs to be better than NRT in the sense that ECs 
provide a similar experience to using cigarettes. However, this MHP explained how he 
perceived EC users to remain classified as smokers, which was the consensus shared by many 
MHPs:  
 “If you just want to do harm reduction and you don’t want to really stop smoking 
then I think its fine to use an electronic cigarette because your lungs definitely feel 
better on an e-cigarette… I couldn’t do research in it, but I think it just sounds logical 
that it’s safer than smoking cigarettes. The problem is then you’re stuck on that so 
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what’s the point? You’re still an addict to nicotine… you’re not classified as a non-
smoker”. (Martin, Community Setting, Psychiatrist, Social Smoker). 
Many MHPs spoke about ECs as being the new craze in the smoking world; referencing the 
increase in number of vape shops on the highstreets over recent years. Discussions regarding 
the perceived glamorisation of ECs, along with product advancement and diversity, led one 
MHP to express how he felt this to be a marketing strategy employed by the tobacco industry 
to maximise profit that was being threatened due to the decrease in tobacco smoking 
prevalence in the general population:  
“Well cynically I feel that the tobacco industry who own all this as I understand as 
well, so to think people aren’t going to smoke cigarettes that they are making sure 
that they corner the market to make e-cigarettes as elaborate as they can to make sure 
that people spend a lot of money on them” (Jack, Community Setting, Social 
Worker, Ex-Smoker) 
The perceived similarity between cigarettes and ECs led many MHPs to predict that ECs 
would be exposed in the future as being harmful products; replicating the timeline of events 
with regard to cigarettes which were once endorsed by medical professionals, but were later 
exposed as lethal products:  
“I think ideally if someone wants to stop smoking then they should stop smoking 
altogether. I think replacing it for lesser evil… in terms of harm, in five or ten years’ 
time we might be given new information that it causes physical health problems as 
well.” (Jenny, Community Setting, Nurse, Social Smoker). 
Theme 2: MHPs consider patient circumstances when making judgements regarding 
EC use for THR purposes in clinical practice. 
 
Sub-theme 1: Treatment context 
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Judgements regarding the suitability of using ECs for THR within a clinical setting were 
sometimes dependent on the treatment context and patients’ individual circumstances. For 
instance, one MHPs expressed how decisions regarding whether or not to allow patients’ to 
use ECs, or even conventional cigarettes, depended upon the patients’ stage of treatment. 
This was spoken in the context of working with patients who have a history of substance 
abuse:  
 “I’ve seen people really suffer and struggle because they are not just doing the 
 patches, they are doing the chewing gum, and they are doing everything! And they are 
 hiding it, and it becomes a new… it’s almost like hiding a bottle of gin, but you’re not, 
 you’re hiding your patches and tablets. So I think it depends on the individual and 
 obviously it’s going to depend on if people are in recovery… it depends on what levels 
 people are at. Obviously if people are really unwell, then in the grand scheme of 
 things, it’s not the end of the world, because like you said, life is so difficult, it’s so 
 hard, so let me have that vape or cigarette. Let’s be real. But, when things do start to 
 improve, with some people with that history of any difficulties with substances, it’s 
 going to be quite different, the process of trying to stop”. (Judith, Community 
 Setting, PWP, Ex-Smoker).  
Some MHPs expressed how ECs may prove to be particularly advantageous by providing a 
similar experience to smoking for inpatients that are unable to smoke outside of hospital 
grounds due to their confinement on the wards. Others elaborated on ECs’ potential in 
providing comfort to these patients who smoke partly for the behavioural rituals: 
“What comes to mind is that there are some wards where I know people can’t maybe 
step out or have leave to smoke… so maybe having an alternative like an e-cigarette 
in that situation maybe something that can help them in that situation” (William, 
Community Setting, PWP, Current Smoker).  
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A minority of MHPs also proposed that ECs could be a positive alternative for patients who 
experience anxiety and thus use the rituals of smoking as a coping mechanism for symptom 
management. This was discussed in the context of traditional NRT not being able to provide 
these cues: 
“So if you think about patients who suffer from anxiety, every time they feel quite 
anxious they go out for a cigarette. It might be that actual physical thing of holding 
the cigarette in their hand and going outside that the vape would replace, rather than 
just sitting there with the patch and feeling quite anxious and not using that 
behaviour.” (Patricia, Community Setting, Trainee PWP, Non-Smoker) 
Sub-theme 2: Patient-centred focus 
 
Patient choice was taken into consideration by some MHPs when determining whether ECs 
would be a helpful THR product for patients within their care. One MHP reflected on the 
high smoking prevalence in this population, which was further used to justify the use of ECs 
in a mental healthcare context:  
“I think it just needs to be absolutely individualised and led by patient choice. The 
patient absolutely needs to be in control of the plan because they are going to have to 
live the plan.” (Sharon, Community Service, Psychiatrist, Ex-Smoker) 
[…] 
“When you first asked the question, I thought wow that’s really stigmatising, why 
should we treat people with severe mental illness differently from people in the 
general population, why shouldn’t we give them the same care? But I think the key is 
that prevalence is different, so peer group is different, so pressure to smoke is 
different. So, abstinence might not be a feasible goal, which makes harm reduction 
more, you know…” (Sharon, Community Service, Psychiatrist, Ex-Smoker) 
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Even among MHPs who were sceptical of ECs, a minority spoke of accounts whereby they 
had encouraged EC use by patients. Although such accounts were rare and predominantly in 
the context of inpatient settings, some MHPs expressed how they would encourage patients 
who are already using ECs to take them on escorted leave, in attempt to dissuade them from 
purchasing tobacco which would inflict financial strain on the patient.  
 “It’s a good way to encourage them as well before we go out on leave, because it’s so 
 expensive so I’m like why don’t you just take your pipe out so you can at least save 
 that £4 and spend it on shopping instead of spending it on tobacco? It’s such a waste 
 of money now.”(Charlotte, Inpatient Service, Admin and ward assistant, Non-
 Smoker). 
Finally, one MHP spoke about how, in spite previously raising concerns regarding ECs, she 
allows ECs to be used by patients in their rooms. Moreover, this MHP elaborated on how, in 
spite of being ill-informed regarding ECs, she had read the smoke-free policy and believed 
they serve to be a popular alternative source of nicotine for patients who could not smoke:  
 “The rule is that they are meant to do it in the bedroom area and we have to 
 constantly encourage them to do that, because what you don’t want to do is normalize 
 any form of smoking behaviour.” (Debbie, Inpatient Service, Nurse and Manager, 
 Ex-Smoker). 
 […] 
“What I felt was I didn’t want the patients to suffer, I didn’t want them to be unhappy, 
I felt that saying “you can’t smoke and that’s it, I don’t want NRT doctor thank you 
very much”, that it was an alternative to support them. And I still maintain that 
view… but I do wonder what is in them [ECs].” (Debbie, Inpatient Service, Nurse 
and Manager, Ex-Smoker)  
4. Discussion 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
18 
 
To our knowledge, this is the first study to explore MHPs perceptions of THR and ECs, as 
well as the decision-making processes underlying their use in mental health clinical settings. 
MHPs adopt a risk-averse approach when making judgements regarding the safety and 
potential effectiveness of ECs in mental healthcare. Specifically in the context of the present 
study, this was predominantly influenced by a perceived obscurity surrounding ECs and 
THR, high prevalence of and reliance upon unscientific and misleading information, and 
perceived analogies between ECs and conventional cigarettes. Among MHPs who expressed 
a degree of endorsement for ECs, this was almost exclusively on a patient by patient basis 
rather than expressing general support for these products. Specifically, patients’ diagnosis 
and treatment setting were considered, along with other individual circumstances.   
We report elsewhere that MHPs in the current study experience constraints in their 
capability, opportunity and motivation to address smoking with their patients, including 
having the belief that smoking is not a priority behaviour to address with mental health 
patients (29). This is a persistent issue which has not only been found in mental healthcare, 
but also among healthcare professionals who work with other socially disadvantaged groups 
experiencing high smoking prevalence, including those in addiction services and the 
homeless (32,33). Interestingly, these socially disadvantaged smokers are often just as 
motivated to quit compared to the general population, and interest in EC and experimentation 
are common among these smokers (34–36). However, smoking prevalence remains 
disproportionately higher in these groups, suggesting that these smokers are lacking the 
support required to convert exclusively to ECs. In relation to the present study, MHPs hold 
many misperceptions and unfounded concerns regarding ECs which may be preventing 
smokers to convert to ECs within these services. Therefore, it is crucial for research to 
explore the cause of these concerns, in order to develop interventions to minimise them. One 
explanation may be that MHPs heavily rely on mental shortcuts when making decisions 
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regarding ECs, especially in light of resource constraints (29). For instance, judging ECs 
based on perceived analogies with conventional cigarettes may be explained by the cognitive 
bias known as representative heuristics, and the tendency to recall information frequently 
presented by the media over less frequent training content and scientific publications may be 
the consequence of information and availability bias (37) (Table 2 presents finding from 
theme 1 using a cognitive psychology framework). Indeed, it is widely known that negative 
press regarding ECs tends to be more prevalent in the media compared with positive 
messages (12), and so it may not necessarily be of surprise that such sources are being 
utilised, particularly among MHPs who feel they lack resources to address smoking with 
patients (29).  
Table 2: A cognitive psychology framework of the present findings (with exemplar 
quotes).  
 
Potential cognitive 
biases 
Example quotes  Participant 
characteristics 
Ambiguity effect/risk 
aversion  
“I think with NRT there is that expectation that you are going to 
reduce down, so it’s clearer. But with vaping, maybe not so much, 
and the paraphernalia around it, there is more potential for it to be a 
lifestyle rather than a stepping stone towards complete cessation.” 
 
“I wonder how healthier the e-cigs are anyway? I haven’t read up 
too much about them, but they don’t seem that healthier because it 
has got the chemicals” 
Clinical 
psychologist, non- 
smoker 
 
 
Healthcare 
assistant, social 
smoker 
Representativeness 
heuristic  
“I think sometimes if you want a cigarette you kind of want the real 
thing. I don’t know how helpful ECs would be because it would still 
be the same rules that you would have to leave and smoke, you 
couldn’t smoke on the wards, and with e-cigarettes it’s the behaviour 
you have to look at.” 
“There is something different they put in [ECs] that’s bad for you. If 
you look at it this way, from say 10 years ago, where can you smoke 
now? Nowhere. So that would make people cut down naturally 
because you can’t smoke anywhere. But e-cigs you can smoke 
anywhere.” 
Mental health 
practitioner, social 
smoker 
 
 
 
Admin and ward 
assistant, non-
smoker 
Focalism 
 
“There is a plastic thing, a small one. I don’t think I’ve ever seen 
someone suck on anything as hard on that than the patients on the 
ward when they were given that instead of access to cigarettes. It 
almost seemed their nicotine intake was more than if they just had the 
odd fag during the day because they were constantly 24 hours a day 
you would see them, then they would go and get a refill. Really 
sucking really deeply… I don’t know what it does or what’s in it, but 
it just struck me… I couldn’t really see what the point of it was other 
than stopping them for actually inhaling smoke.”  
Clinical 
psychologist, ex-
smoker 
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“The thing is with smoking it’s trying to get them away from their 
addiction, and that is not getting them away from their addiction. 
Even though it’s better for their health it’s still an addiction. They 
are still addicted to something.”  
Admin and ward 
assistant, non-
smoker 
Availability heuristic “I can’t remember if ECs are covered in the e-learning… I can’t 
remember if I read or heard it, but it was over the weekend, that 
young people are taking up vaping rather than smoking, which that’s 
not what its meant to be… its meant to be an aid to stopping, isn’t it.”  
“I read something in the paper that the percentage of harm they are 
doing compared to cigarettes is not a lot of percentage difference.” 
Nurse & team 
leader, social 
smoker 
 
 
Admin and ward 
assistant, non-
smoker 
 
Future research  
 In light of the present findings, more efforts are needed to improve the knowledge 
about ECs among MHPs, in order to guide clinical practice and decision making with respect 
to ECs as a THR intervention. Due to the heterogeneity of the services involved in the present 
study, future work should explore attitudes and decision-making regarding THR and ECs in 
each area of mental health (i.e. inpatient, community, primary care, etc.) to generate more in-
depth issues that may be unique to different service types. Moreover, future research should 
expand this to other settings supporting vulnerable groups presenting with high smoking 
prevalence and low cessation rates, including those who present with poor MH and coexisting 
health and social needs (e.g. homelessness and substance users).  
 
Strengths and limitations  
 The evidence-base around e-cigarettes is constantly developing and so the findings 
are limited to the time when they were gathered and analysed. These qualitative data from a 
small purposive sample cannot be generalized to the population of mental health 
professionals in the UK or internationally, and so further research is warranted. Focus groups 
were used to encourage discussions that were interactive thus generating further data; 
however, this means it is not possible to eliminate the possibility of a ‘bandwagon effect’, 
whereby participants agree with the view of others against their own internal beliefs. This 
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may be particularly the case in focus groups where MHPs had differing opinions to those in 
positions of authority (i.e. team leaders or managers). However, the fact that focus groups 
involved professionals with backgrounds from a wide variety of disciplines also serves as a 
strength to this study by representing views of a multidisciplinary culture which is often the 
case in healthcare. This is valuable, as studies in the past have often solely recruited medical 
professionals, such as general practitioners and nurses. Finally, as is true of qualitative 
research in general, our account cannot claim to provide a fully objective view, given 
intrinsic biases and influences of the researchers involved in the analysis. However, we did 
attempt to triangulate findings by deviant case analysis and discussion about and agreement 
on themes among co-authors.  
 
Conclusion 
 
In summary, our findings provide insight into how MHPs perceive THR and ECs, and how 
they make decisions regarding the implication of such approaches in mental healthcare. 
These findings suggest that improved dissemination of the evidence-base supporting THR 
and ECs as effective tobacco control interventions is warranted. Further exploration is 
required in order to determine how the acceptability of THR and ECs can be improved 
among MHPs, as this is essential if such approach is to be successfully integrated across the 
mental healthcare pathway as a viable tobacco control approach for smokers with mental 
health conditions. 
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Appendix 1 
 
Scene-setting and instructions to participants (10 mins) 
Introductions 
 Facilitator and assistant facilitator introduce selves 
 
“Thank you for volunteering to take part in this focus group. Your point of view is important and 
we appreciate the time that you have given to take part.  
This focus group discussion is being held to find out about your thoughts and feelings about 
smoking amongst people with mental illness and ways to reduce the rate of smoking amongst this 
group. The discussion should take no more than 45 minutes. As we mentioned in the information 
about this study, we would like to record this discussion so that we have a record of everything 
that has been discussed. We would like to assure you that this discussion is confidential and all 
personal information will be anonymised. The tapes will be kept safely in a locked room until they 
are transcribed, after which they will be destroyed.  
Can I just confirm that everyone is happy for the discussion to be recorded? 
We’d like to encourage you to answer and comment as accurately and truthfully as possible. To 
protect everyone’s confidentiality, we would also like to ask you to refrain from discussing the 
comments of other group members outside of the focus group. Whilst we’d like you to be as 
involved as possible, if there are any questions or discussions that you do not want to answer to 
of participate in, you do not have to do so. If at any point you’d like to withdraw from the study, 
you are free to leave at any point.” 
Cover ground rules: 
 Important to treat focus group as a relaxed discussion - it is not a question and answer 
session. 
 Only one person speaking at a time - please wait until others have finished before 
commenting. 
 No right or wrong answers - we are just interested in what you have to say. 
 Please say what you really think and feel, and feel free to respond to other people’s 
comments. There’s no need to wait for me to ask you questions. 
 Any questions before we begin? 
 
Introductions (5 mins) 
 Ask all group members to introduce themselves by name and role, and state what they 
had for breakfast (ice-breaker). Ask participants to speak clearly to facilitate identification 
of individuals during transcription. 
Main discussion (45 – 60 mins) 
Questions Prompts 
1. To start this discussion off, what are your 
experiences of offering patients advice or 
assistance to quit smoking, and how could 
you have overcome any difficulty in doing 
this?  
Have these experiences been positive or 
negative? 
Do you feel it is part of your job role? If 
not, why not?  
Do you think it has/would have any 
effects on your relationship with 
patients? 
-Any experiences of it doing so? 
-Any cases where it has helped? 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
30 
 
2. What do you think about the idea of harm 
reduction (i.e. replacing some or all cigarette 
smoking with a less harmful product)?  
Do you think it would be an effective or 
appropriate approach? 
Do you think it has any benefits over 
complete cessation?  
Can you foresee any problems with 
taking this approach?  
3. What do you think about electronic cigarettes? Do you feel you have enough knowledge 
of e-cigarettes as a harm reduction tool? 
Any benefits or drawbacks in comparison 
to other treatments? 
Any benefits or drawbacks in people with 
mental health issues? 
How much do you know about the 
different types of e-cigarettes? 
Any personal experiences of using them? 
4. How would you feel about offering e-
cigarettes to patients to help them to stop or 
reduce smoking?  
What are your experiences of demand for 
e-cigarettes from service users? 
What would make this difficult to do?  
What would make this easier to do?  
5. The recent Smoke Free Policy includes 
guidance on facilitating service users’ use of e-
cigarettes. Have you read the policy? What are 
your thoughts on this policy? 
Do you have any experiences of 
implementing this policy? 
Have you had any difficulties in 
implementing this policy? 
Do you have any suggestions for how the 
policy could be improved? 
***FOR FORENSIC TEAMS*** 
6. Do you think that working with forensic service 
users has or would have any effect on how you 
do or would address their smoking 
behaviours? 
 
7. Before we finish this discussion, is there 
anything else anyone would like to add? (ask 
each group member individually) 
 
Debrief and end 
“Thank you to everyone for coming along – we’ve had a really productive and interesting 
discussion and you’ve all made some great contributions.” 
(Give everyone an opportunity to request results of the study and provide feedback) 
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Highlights  
 Quitting smoking is difficult to achieve among smokers with mental health conditions 
 ECs may be a promising harm reduction intervention for these smokers 
 MHPs hold misconceptions regarding ECs which may undermine this intervention. 
 Improved dissemination of THR and EC evidence-base is needed in mental healthcare 
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